Arkolith/Insider Trading/CLB/Form 4

Klingensmith Harvey Robert

DirectorCore Laboratories Inc. /DE/ (CLB) · full profile →Form 4 · filed Apr 7, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 1, 2026Option exercise(M)8K—$050K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 1, 2026Grant(A)8K—$08K
Apr 1, 2026Option exercise(M)8K—$00

Transaction Codes

M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-145945) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML